Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conference

Rhea-AI Summary

Pacific Biosciences of California (NASDAQ: PACB) announced that its executives will speak at the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021, at 4:00 pm Eastern Time (1:00 pm Pacific Time). The event will feature a panel discussion, and live webcasts will be accessible on the company's investor page, with replays available for at least 30 days. Pacific Biosciences specializes in highly accurate long-read sequencing technology, empowering life scientists globally to explore genetic variations for numerous applications.

News Market Reaction – PACB

+2.45%

+2.45% Session move

In the trading session that priced this news, PACB gained 2.45%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MENLO PARK, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conference:

• UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021, Panel Discussion at 4:00 pm Eastern Time (1:00 pm Pacific Time)
  

The live webcasts can be accessed at the company’s investors page at investor.pacificbiosciences.com. The replays will be available for at least 30 days following the presentation.

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. For more information please visit www.pacb.com and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacificbiosciences.com

Media:
Jen Carroll
858.449-8082
pr@pacificbiosciences.com

 

FAQ

When will PACB executives speak at the UBS Genomics 2.0 Summit?

PACB executives will speak at the UBS Genomics 2.0 and MedTech Innovations Summit on August 11, 2021, at 4:00 pm Eastern Time.

How can I access the live webcast for the PACB event?

The live webcast for the PACB event can be accessed via the company's investor page at investor.pacificbiosciences.com.

How long will the PACB event replays be available?

Replays of the PACB event will be available for at least 30 days following the presentation.

What technology does Pacific Biosciences specialize in?

Pacific Biosciences specializes in highly accurate long-read sequencing technology, specifically Single Molecule, Real-Time (SMRT) Sequencing.